Advances in the understanding of the mechanism of action of IVIg.
about
Clinical Experience with Octagam® 10 %, a solvent detergent virus inactivated intravenous immunoglobulin: a Canadian retrospective review of utilizationUse of intravenous immunoglobulin in pediatric practiceThe role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literatureAnalysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionationα(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro.CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activityRole of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis.The Japanese guidelines for the management of sepsis.Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial.Immune mediated diseases and immune modulation in the neurocritical care unitImmunoglobulin expression in non-lymphoid lineage and neoplastic cells.Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.Immunomodulatory effects of intravenous immunoglobulins (IVIGs) in HIV-1 disease: a systematic review.Intravenous immunoglobulin in pediatrics: A review.Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.Complement and Antibody-mediated Enhancement of Red Blood Cell Invasion and Growth of Malaria Parasites.Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.Eastern Equine Encephalitis Treated With Intravenous Immunoglobulins.Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?Dose-dependent inhibition of demyelination and microglia activation by IVIG.Intravenous immunoglobulin-induced acute thrombocytopenia.Intravenous immunoglobulin for treatment of neuromuscular disease.Emerging treatment options for the management of pemphigus vulgaris.
P2860
Q26741124-54B2003F-81AE-4960-B43D-6BE38E3D84C6Q27011481-1819F9CD-A190-4A09-9DC4-F7534C2EE9A5Q28067526-7E42ADC0-144B-4C86-AAE9-FBDCD2CFE45EQ28728886-5374E76F-7423-4BF7-A1AE-23D1AB6686DCQ30524065-AA4B2125-482A-4EC0-9905-CBC6A66D1FCAQ33419269-58DC446E-8024-4C16-9404-21F2BB2516D9Q33677718-4F3368DC-2955-48E1-A8D1-BCF92233E4B0Q33817905-939FD46D-A8CA-4338-A789-2F3F3784DA10Q33868085-F6E43D5F-BA11-4B87-8187-B17BBE54ED5BQ35107094-FDDE5A7C-87B2-44F1-94C2-C8A6B859D089Q35187840-79A43979-722F-47D9-B093-670FDFC10CFBQ35729575-36859C87-9473-4312-9575-C6E574A66040Q37402190-F71EC7DC-DDB1-4795-9A3F-AFC5B09AB302Q37535345-AD699816-02FD-478E-BE5C-1960DEC67212Q37773248-E7502CBE-B0DC-4DAF-BE8C-D9947588105AQ37822450-1512FA25-7729-44C8-9857-33CA7491415CQ38266015-1EEF1FF3-ECFB-4CD1-B4E3-B43E3B3B28B3Q38842992-9F295902-0281-4766-B95B-7991E2A4FC1AQ38849729-73E4AA8D-ECAB-4B87-B207-E66BF7C0E225Q38900642-4260A480-91D2-4D2A-A43A-3713A3EF17D0Q40842013-1AB1EE18-3486-43D8-B2C3-635B3214DEC6Q41520774-6261CB58-A5E0-4F44-8E4D-AB6C4C936450Q41819438-82B3659C-52D5-43A1-832A-B984BF57D43CQ48203712-F08CDA1D-2DC9-4339-9425-2E02A8865207Q50133537-57CBAFC0-E471-43FD-B54A-95958C3F0B67Q55433740-C4853BCD-EEEB-4D6D-8591-A895EE70C4A3
P2860
Advances in the understanding of the mechanism of action of IVIg.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in the understanding of the mechanism of action of IVIg.
@en
Advances in the understanding of the mechanism of action of IVIg.
@nl
type
label
Advances in the understanding of the mechanism of action of IVIg.
@en
Advances in the understanding of the mechanism of action of IVIg.
@nl
prefLabel
Advances in the understanding of the mechanism of action of IVIg.
@en
Advances in the understanding of the mechanism of action of IVIg.
@nl
P1433
P1476
Advances in the understanding of the mechanism of action of IVIg.
@en
P2888
P356
10.1007/S00415-008-3002-0
P478
255 Suppl 3
P577
2008-07-01T00:00:00Z